PDE5A and erectile dysfunction: This marker has been identified as a predictor of therapeutic response to PDE5 inhibitors in erectile dysfunction [38], reinforcing the concept that systemic inflammatory burden can modulate vascular responsiveness and possibly drug efficacy.